Latest stories on ICLR
SUNFLOWER Lupus Trial Puts AstraZeneca and ICON in Focus for Long‑Term Investors
TipRanks58 · neutralproduct/pr
ICON Plc: FY25 Shows Reset Before Reacceleration
Seeking Alpha42 · neutralearnings
Icon Plc Flags Material Weakness in Internal Controls, Raising Financial Reporting and Regulatory Risks
TipRanks22 · bearishgeneral
ICON Public Limited Company (ICLR) Q4 2025 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Icon Q4 Earnings Call Highlights
Yahoo Top42 · neutralearnings
ICON drops after Q4 earnings miss
Seeking Alpha33 · bearishearnings
Icon Non-GAAP EPS of $2.52 misses by $0.22, revenue of $2.11B beats by $170M
Seeking Alpha47 · neutralearnings
ICON Unveils 2025 Results, Restates Prior Years After Audit Probe Finds Revenue Overstatement
TipRanks33 · bearishearnings
ICON Faces Nasdaq Deficiency Notice as It Delays 2025 Annual Report Filing
TipRanks33 · bearishgeneral